Visma acubiz A/S – Trademark Portfolio
Entity Type: 99
Visma acubiz A/S holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include A and ACUBIZ.
Gærtorvet 3
DK-1799 København V
Showing of trademarks Trademarks
Trademark Classifications
Visma acubiz A/S's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Visma acubiz A/S have?
Visma acubiz A/S has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.
What trademark classes does Visma acubiz A/S file in?
Visma acubiz A/S files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Visma acubiz A/S's most well-known trademarks?
Visma acubiz A/S's registered trademark portfolio includes well-known marks such as A and ACUBIZ. These are among 2 currently registered trademarks in the portfolio.
What is Visma acubiz A/S's trademark registration success rate?
Visma acubiz A/S has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.